OCEA Stock - Ocean Biomedical, Inc.
Unlock GoAI Insights for OCEA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | $-2,481,639 | $-566,558 | $-1,652,000 | $-232,000 |
| Net Income | $-3,301,000 | $565,470 | $-62,344,000 | $-1,653,000 | $-232,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.12 | $-0.05 | $-0.04 | $-0.08 | $-0.01 |
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.
Visit WebsiteEarnings History & Surprises
OCEAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Apr 8, 2025 | — | $0.02 | — | — |
Q1 2025 | Jan 13, 2025 | $-0.23 | $-0.20 | +13.0% | ✓ BEAT |
Q4 2024 | Dec 23, 2024 | $-0.19 | $-0.63 | -231.6% | ✗ MISS |
Q3 2024 | Sep 27, 2024 | $-0.22 | $-0.63 | -185.0% | ✗ MISS |
Q2 2024 | Apr 15, 2024 | $-0.15 | $-0.53 | -253.3% | ✗ MISS |
Q1 2024 | Feb 28, 2024 | $-0.19 | — | — | — |
Q3 2023 | Sep 29, 2023 | $-0.15 | $-0.53 | -253.0% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.20 | $-0.39 | -95.0% | ✗ MISS |
Q2 2023 | May 1, 2023 | $-0.16 | $0.43 | +368.7% | ✓ BEAT |
Q1 2023 | Feb 15, 2023 | — | $0.03 | — | — |
Q4 2022 | Oct 17, 2022 | — | $-0.08 | — | — |
Q3 2022 | Jul 11, 2022 | — | $-0.73 | — | — |
Q2 2022 | Apr 25, 2022 | — | $-0.27 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.62 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.36 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.40 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-1.35 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about OCEA
What is OCEA's current stock price?
What is the analyst price target for OCEA?
What sector is Ocean Biomedical, Inc. in?
What is OCEA's market cap?
Does OCEA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to OCEA for comparison